. Author manuscript; available in PMC: 2014 Nov 1.

Published in final edited form as: Magn Reson Imaging. 2013 Aug 15;31(9):10.1016/j.mri.2013.07.002. doi: 10.1016/j.mri.2013.07.002

Table 1.

Patient and tumor characteristics.

Variable	Value
Number of patients	21
Patient age (years)
Mean	45
Range	28–60
Baseline tumor diameter, clinical (cm)
Mean	5.6
Range	2–12
Immunostaining
ER+ and/or PR+	7
HER2+ (including ER+ and ER−)	7
Triple negative	7
Tumor grade
Low	3
Intermediate	6
High	12
Surgery
Mastectomy	10
Breast conservation therapy	11

ER = estrogen receptor. HER2 = human epidermal growth factor receptor 2 (ErbB2). PR = progesterone receptor. “Triple negative” = ER−/PR−/HER2−.